Following the observation that Mito-Met enhances PKD1 activation, we wanted to determine whether Mito-Met can also increase the activation of Akt because Akt has been previously shown to have neuroprotective effects in cell culture and animal models of PD (Ries et al., 2006; Gunjima et al., 2014). Here, AKT1 is linked to Parkinson disease.